Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

PET Imaging Toward Individualized Management of Urologic and Gynecologic Malignancies.

PET Imaging Toward Individualized Management of Urologic and Gynecologic Malignancies. PET clinics Sonni, I., Iagaru, A. 2016; 11 (3): 261-272

Abstract

Advances in the understanding of cellular and molecular basis of tumor progression have spurred interest in the development of new targeted agents that are changing the therapeutic management of patients with cancer. In parallel to progression in the therapeutic area, new PET radiopharmaceuticals are being developed to guide the use of such targeted therapies. This article aims to give an overview on the role of PET imaging in the individualized management of patients affected by urologic and gynecologic malignancies, focusing on the most promising targets for therapies and for molecular imaging using PET.

View details for DOI 10.1016/j.cpet.2016.02.007

View details for PubMedID 27321030